Cross-Training and Locomotor Abilities in Cerebral Palsy

December 19, 2024 updated by: Tamer Mohamed El-Saeed, Cairo University

Effect of Cross-Training on Locomotor Abilities in Children with Spastic Hemiparesis

The purpose was to investigate the effect of cross-training as a method of unilateral motor priming on locomotor abilities in children with spastic unilateral cerebral palsy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Thirty children with spastic unilateral cerebral palsy were recruited from different rehabilitation centers. They were assigned randomly into two groups. Children in the control group (A) were engaged in a selected physical therapy program while those in the experimental group (B) received cross-training program followed by application of the same selected physical therapy program received by group (A). The treatment programs were conducted five times per week for six successive weeks. Measurements obtained included active ankle dorsiflexion range of motion (AROM), and the speed of walking obtained by 10-meter walking test. These measures were recorded two times: pre- and post-treatment.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Cairo
      • Giza, Cairo, Egypt, 12613
        • Faculty of physical therapy, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Spasticity grade 1 to 1+, according to the Modified Ashworth Scale.
  • Can stand and walk autonomously.
  • Able to follow verbal commands and instructions.

Exclusion Criteria:

  • Fixed musculoskeletal deformities
  • significant cognitive disorders
  • significant perceptual disorders
  • significant auditory disorders
  • significant visual disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
receive an experimental intervention
Other: Designed rehabilitation program
Program of exercises to enhance abilities
Active Comparator: Control
another therapy used to treat the same condition
Other: Physical Therapy
Exercises to improve locomotor abilities of children with CP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
active ankle dorsiflexion range of motion (AROM)
Time Frame: Baseline and at the end - through study completion, an average of 1 year
Baseline and at the end - through study completion, an average of 1 year
10-meter walking test
Time Frame: Baseline and at the end - through study completion, an average of 1 year
Baseline and at the end - through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Actual)

December 1, 2024

Study Completion (Actual)

December 15, 2024

Study Registration Dates

First Submitted

December 15, 2024

First Submitted That Met QC Criteria

December 19, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 19, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/004588

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy (CP)

Clinical Trials on Designed rehabilitation program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe